| CSB00025 | 重组人红细胞生成素注射液 | Human Erythropoietin | Injection | Biological Products(2) | Supplementary Application | 2000-10-18 | 沈阳三生制药股份有限公司 | Shenyang Sunshine Pharmaceutical Co Ltd | In Approval | | view |
| CYSB2101258 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-11-04 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| CYSB2400065 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-03-09 | | | | | view |
| CYSB2200100 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-03-30 | | Kexing Biopharm Co Ltd | | | view |
| CYSB2400200 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-08-08 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| CYSB2200215 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-08-26 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| JYSB2200154 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2022-08-12 | | | | | view |
| CXSL2200533 | 长效重组人促红素注射液 | | Injection | Biological Products(3.3) | New Drug Application | 2022-10-20 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| CXSS2101074 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products(3.4) | New Drug Application | 2021-12-22 | | Shanghai Chemo Wanbang Biophama Co Ltd | | | view |
| CYSB2200099 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-03-30 | | Kexing Biopharm Co Ltd | | | view |
| CXSL2200530 | 长效重组人促红素注射液 | | Injection | Biological Products(3.3) | New Drug Application | 2022-10-20 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| CYSB2400127 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products(3.4) | Supplementary Application | 2024-05-22 | | | | | view |
| CYSB2101006 | 重组人促红素注射液(CHO细胞) | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-03-22 | | Beijing Four Rings Bio-Pharmaceutical Co Ltd | | | view |
| JYSB2300074 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2023-04-26 | | | | | view |
| CXSL2200534 | 长效重组人促红素注射液 | | Injection | Biological Products(3.3) | New Drug Application | 2022-10-20 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| CYSB2400178 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-07-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2101011 | 重组人促红素注射液(CHO细胞) | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-03-22 | | Beijing Four Rings Bio-Pharmaceutical Co Ltd | | | view |
| CXSL2200444 | 聚乙二醇重组人促红素注射液 | | Injection | Biological Products(1) | New Drug Application | 2022-09-07 | | Shenzhen Sciprogen Bio-pharmaceutical Co Ltd | | | view |
| CYSB2400067 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-03-09 | | | | | view |
| CYSB2200036 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-02-11 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
